(Total Views: 141)
Posted On: 08/14/2020 11:00:46 AM
Post# of 89535

$ADMP News Article - Adamis Pharmaceuticals Announces Pre-IND Feedback from FDA Enabling Advancement of Tempol, a Novel Anti-Inflammatory and Anti-Oxidant Drug for the Treatment of COVID-19 https://marketwirenews.com/news-releases/adam...81950.html


My Twitter: WhyteStocks